Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-19T00:01:30.452Z Has data issue: false hasContentIssue false

A Comparative Trial of Diazepam (Valium) and Amylobarbitone

Published online by Cambridge University Press:  29 January 2018

N. S. Capstick
Affiliation:
From the Department of Psychological Medicine, St. Bartholomew's Hospital, London
M. F. Corbett
Affiliation:
From the Department of Psychological Medicine, St. Bartholomew's Hospital, London
C. M. B. Pare
Affiliation:
From the Department of Psychological Medicine, St. Bartholomew's Hospital, London
I. G. Pryce
Affiliation:
From the Department of Psychological Medicine, St. Bartholomew's Hospital, London
W. Linford Rees
Affiliation:
From the Department of Psychological Medicine, St. Bartholomew's Hospital, London

Extract

Short acting barbiturates such as amylobarbitone have long been the standby for relief of anxiety—certainly any new drugs introduced for the relief of such symptoms must stand comparison with these. Furthermore such symptoms are well known to be modifiable by such variables as the attitude of the doctor. For this reason a trial of such a new drug must be carried out under blind conditions.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1965 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Jenner, F. A., Kerry, R. J., and Parkin, D. (1961). J. Ment. Sci., 107, 575.Google Scholar
Kerry, R. J., and Jenner, F. A. (1962). Psychopharmacologia, 3, 302.Google Scholar
Marks, J. (1962). Journal of New Drugs, 2, No. 2, 71.CrossRefGoogle Scholar
Sainsbury, P., and Lucas, C. J. (1959). Brit. med. J., ii, 737740.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.